Robyn A A Oldham

Title: Robyn A A Oldham: Innovator in Immunotherapy

Introduction

Robyn A A Oldham is a notable inventor based in Milwaukee, WI (US), recognized for his contributions to the field of immunotherapy. With a total of 4 patents, Oldham has made significant strides in developing innovative treatments for cancer.

Latest Patents

Oldham's latest patents include groundbreaking work on bispecific antibodies targeting CD30 and CD3. One of his inventions, titled "Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD30+ malignancies," provides novel bispecific antibodies that bind to human CD30, along with methods for treating cancer using these antibodies. Another patent, "Anti-CD30 antibodies," presents innovative antibodies and antigen-binding fragments that also target human CD30, including single-chain variable antibodies and chimeric antigen receptors, with disclosed methods for cancer treatment.

Career Highlights

Throughout his career, Oldham has worked with esteemed institutions such as the Medical College of Wisconsin and the University of Virginia. His research has focused on advancing cancer therapies, particularly through the development of bispecific antibodies.

Collaborations

Oldham has collaborated with notable colleagues, including Jeffrey A Medin and Mary L Faber, who have contributed to his research endeavors.

Conclusion

Robyn A A Oldham's innovative work in immunotherapy and his numerous patents highlight his significant impact on cancer treatment. His contributions continue to pave the way for advancements in medical science.